Latest News & Updates

Breaking News

  • 23 hours ago

  • Vaibhavi M.

Taro Pharmaceutical Launches AB-Rated Perampanel Oral Suspension as Generic Alternative to Fycompa
Breaking News
60 Degrees Pharmaceuticals Secures Exclusive Option with Florida State University for Castanospermine Tick-Borne Disease Program

Vaibhavi M.

Other trending news you may like to read

Taro Pharmaceutical Launches AB-Rated Perampanel Oral Suspension as Generic Alternative to Fycompa

Taro Pharmaceutical launches AB-rated perampanel 0.5 mg/mL oral suspension, a generic equivalent to Fycompa, opening formulary substitution pathways.

Vaibhavi M.

Pharma Now

60 Degrees Pharmaceuticals Secures Exclusive Option with Florida State University for Castanospermine Tick-Borne Disease Program

60 Degrees Pharma pivots castanospermine toward prescription drug development after FDA NDI discussions, securing an exclusive option with Florida State University.

Vaibhavi M.

Pharma Now

3PBIOVIAN Sets Out Scalability Framework for Viral Vector GMP Transition in Gene Therapy

3PBIOVIAN outlines how early process design decisions in viral vector manufacturing determine GMP success at commercial scale.

Vaibhavi M.

Pharma Now

Stipple Bio Appoints Roland Gendron As Chief Business Officer To Accelerate Oncology Growth Strategy

Stipple Bio names Roland Gendron as CBO to lead business development and partnerships as STP-100 advances toward clinical studies on the back of a $100M Series A financing.

Simantini Singh Deo

Pharma Now